Susan Sholtis Net Worth

The estimated Net Worth of Susan Sholtis is at least $3.7 Million dollars as of 7 May 2022. Ms. Sholtis owns over 12,500 units of PetIQ Inc stock worth over $765,265 and over the last 7 years she sold PETQ stock worth over $497,661. In addition, she makes $2,434,320 as President at PetIQ Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Sholtis PETQ stock SEC Form 4 insiders trading

Susan has made over 13 trades of the PetIQ Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 12,500 units of PETQ stock worth $383,000 on 7 May 2022.

The largest trade she's ever made was exercising 12,500 units of PetIQ Inc stock on 7 May 2022 worth over $383,000. On average, Susan trades about 2,735 units every 57 days since 2018. As of 7 May 2022 she still owns at least 24,976 units of PetIQ Inc stock.

You can see the complete history of Ms. Sholtis stock trades at the bottom of the page.

Susan Sholtis biography

Susan Sholtis serves as President of the Company. Ms. Sholtis has served as President since October 2018. She previously served as a director from March 2018 to October 2018. Prior to her appointment as President, Ms. Sholtis served as Global Marketing Head in the Health Division at Reckitt Benckiser since 2017. From 2016 to 2017, Ms. Sholtis served as Head of North America Commercial Operations at Merial and was responsible for transitioning North America operations to Merial’s new owner, Boehringer Ingelheim. Prior to that, from 2006 to 2016, Ms. Sholtis served in a number of positions at Mead Johnson Nutrition, most recently as Head of Global Marketing. Ms. Sholtis earned a Bachelor’s degree from Butler University and a Masters of Business Administration from Emory University.

What is the salary of Susan Sholtis?

As the President of PetIQ Inc, the total compensation of Susan Sholtis at PetIQ Inc is $2,434,320. There are no executives at PetIQ Inc getting paid more.

How old is Susan Sholtis?

Susan Sholtis is 53, she's been the President of PetIQ Inc since 2018. There are 7 older and 9 younger executives at PetIQ Inc. The oldest executive at PetIQ Inc is Ronald Kennedy, 73, who is the Independent Director.

What's Susan Sholtis's mailing address?

Susan's mailing address filed with the SEC is C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE, ID, 83616.

Insiders trading at PetIQ Inc

Over the last 7 years, insiders at PetIQ Inc have traded over $329,773,374 worth of PetIQ Inc stock and bought 191,694 units worth $3,985,118 . The most active insiders traders include Mark L First, Helios Partners Iv, L.P.Eos..., and Will Santana. On average, PetIQ Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,635,992. The most recent stock trade was executed by William J. Carter on 28 August 2024, trading 5,000 units of PETQ stock currently worth $153,200.

What does PetIQ Inc do?

petiq is founded with a love of pets and a desire to improve pet lives with veterinarian recommended pet products, made here in the usa. petiq offers pet prescription medications, over-the-counter flea & tick preventatives, health & wellness supplements, and dog & cat treats - at savings to other brand name alternatives. the company's portfolio of brands includes minties® dental treats, advecta® and petaction® flea and tick preventatives, vetiq® health & wellness, delightibles® cat treats, and betsy farms® dog treats. products are distributed nationally through traditional retail partners. petiq is headquartered in eagle, idaho with manufacturing and distribution facilities in springville, utah; plano, texas; and daytona beach, florida. to learn more, visit petiq.com.

Complete history of Ms. Sholtis stock trades at PetIQ Inc

PetIQ Inc executives and stock owners

PetIQ Inc executives and other stock owners filed with the SEC include:

• Susan Sholtis,
  President
• Michael Smith,
  Executive Vice President - Products
• McCord Christensen,
  Chairman of the Board, Chief Executive Officer
• John Newland,
  Chief Financial Officer
• Michael A. Smith,
  Pres & COO
• Robert Michael Herrman,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Scott Huff,
  Independent Director
• Mark First,
  Lead Independent Director
• James Clarke,
  Independent Director
• Ronald Kennedy,
  Independent Director
• Larry Bird,
  Independent Director
• Jeff Sonnek,
  IR Contact Officer
• R. Michael Herrman,
  General Counsel, Secretary
• Lauren Olavessen,
  Senior Vice President, Chief Medical Officer
• Will Santana,
  Director
• John Pearson,
  Sr. VP & Head of Services Division
• Zvi Glasman,
  Chief Financial Officer
• John Newland,
  Chief Financial Officer
• Dr. Lauren Olavessen D.V.M.,
  Sr. VP & Chief Medical Officer
• Susan Sholtis,
  Pres
• McCord Christensen,
  Chairman & CEO
• Kenneth C. Walker,
  
• Scott Adcock,
  President
• Helios Partners Iv, L.P.Eos...,
  
• Gary G Michael,
  
• Allan Hall,
  
• Sheryl Oloughlin,
  
• Kimberly Lefko,
  
• Zvi Glasman,
  CHIEF FINANCIAL OFFICER
• William J. Carter,
  EVP, GENERAL COUNSEL
• John Paul Pearson,
  EVP, SERVICES & MANUFACTURED